What Orthopedic Executives Said About 2Q21
Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact. Aug 18, 2021
We've found 289 results
Amplitude Surgical Looks to Rebuild Momentum
The company closed its 2021 fiscal year up high single digits compared to 2020 but is still well below historical norms. Aug 16, 2021
OrthoPediatrics Organic Growth Driven by Market Share Gains
The company's revenue grew double-digits in 2Q21 on the strength of share gains instead of recapturing backlogged procedures. Aug 11, 2021
Anika Therapeutics Remains On Course In Transition Year
The company benefitted from improving COVID conditions in 2Q21 and remains on course to achieve both short and long-term strategic goals. Aug 10, 2021
WishBone Medical Receives $10 Million in Growth Capital
The funding will support product development and manufacturing to meet increasing market demand for pediatric orthopedic devices. Aug 10, 2021
Orthofix Benefits from New Products to Offset COVID Impact
In 2Q21, the company grew modestly compared to the same period in 2019 due to newer products like the M-6 disc and FITBONE. Aug 09, 2021
Vericel on Track for Robust Second Half in 2021
The company outperformed expectations so far for 2021 and remains on track to realize growth in the 30% range for the full year. Aug 09, 2021
Globus Medical Enters Virtuous Cycles Through Robotics
The company set a new revenue record in 2Q21 thanks in large part to the synergistic impact of its ExcelsiusGPS robotic system. Aug 05, 2021
Zimmer Biomet Looks to Technology to Untrack Knee Franchise
In 2Q21 the company made impressive gains in sports medicine and extremities but has yet to find a path to above-market growth in knees. Aug 04, 2021
ConMed Stays the Course During Transition Year
The company bounced back in 2Q21 from the pandemic low point but, as expected, its orthopedic business remains well off its 2019 pace. Aug 03, 2021
